Post-Trial Access to Drugs in Developing Nations

More about the book

Focusing on the ethical implications of clinical research in developing countries, this book addresses global health inequalities and the rights of research participants. It explores the regulatory frameworks and ethical oversight necessary for safeguarding these rights during clinical trials. By analyzing patent and non-patent barriers to drug access, it proposes a middle ground approach for achieving global health justice. The discourse encompasses intellectual property, international regulations, and trade agreements, culminating in a comprehensive ethical debate on health rights and responsibilities.